MedDataX Logo

Clinical Trials

Showing trials with last updates posted in 2016.

NCT00908414 | WITHDRAWN | PHASE1
0 Participants

PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2009-05-31
Completion: 2009-10-31
Conditions
HIV Infections
Interventions
DRUG
No Results Yet
NCT00897442 | COMPLETED
275 Participants

Collecting Tumor Samples From Patients With Gynecological Tumors

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 1992-06-30
Completion: 2016-01-31
Conditions
Borderline Ovarian Clear Cell Tumor Borderline Ovarian Serous Tumor Cervical Adenocarcinoma Cervical Adenosquamous Carcinoma Cervical Small Cell Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Childhood Embryonal Rhabdomyosarcoma Childhood Malignant Ovarian Germ Cell Tumor Endometrioid Stromal Sarcoma Gestational Trophoblastic Tumor Malignant Mesothelioma Malignant Ovarian Epithelial Tumor Melanoma Neoplasm of Uncertain Malignant Potential Ovarian Brenner Tumor Ovarian Clear Cell Cystadenocarcinoma Ovarian Serous Cystadenocarcinoma Paget Disease of the Vulva Recurrent Cervical Carcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Ovarian Germ Cell Tumor Recurrent Primary Peritoneal Carcinoma Recurrent Uterine Corpus Carcinoma Recurrent Vaginal Carcinoma Recurrent Vulvar Carcinoma Stage I Ovarian Cancer Stage I Uterine Corpus Cancer Stage I Vaginal Cancer Stage I Vulvar Cancer Stage IA Cervical Cancer Stage IA Fallopian Tube Cancer Stage IA Ovarian Cancer Stage IA Ovarian Germ Cell Tumor Stage IB Cervical Cancer Stage IB Fallopian Tube Cancer Stage IB Ovarian Cancer Stage IB Ovarian Germ Cell Tumor Stage IC Fallopian Tube Cancer Stage IC Ovarian Cancer Stage IC Ovarian Germ Cell Tumor Stage II Ovarian Cancer Stage II Uterine Corpus Cancer Stage II Vaginal Cancer Stage II Vulvar Cancer Stage IIA Cervical Cancer Stage IIA Fallopian Tube Cancer Stage IIA Ovarian Cancer Stage IIA Ovarian Germ Cell Tumor Stage IIB Cervical Cancer Stage IIB Fallopian Tube Cancer Stage IIB Ovarian Cancer Stage IIB Ovarian Germ Cell Tumor Stage IIC Fallopian Tube Cancer Stage IIC Ovarian Cancer Stage IIC Ovarian Germ Cell Tumor Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor Stage III Cervical Cancer Stage III Uterine Corpus Cancer Stage III Vaginal Cancer Stage III Vulvar Cancer Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Cancer Stage IIIA Ovarian Germ Cell Tumor Stage IIIA Primary Peritoneal Cancer Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Cancer Stage IIIB Ovarian Germ Cell Tumor Stage IIIB Primary Peritoneal Cancer Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Cancer Stage IIIC Ovarian Germ Cell Tumor Stage IIIC Primary Peritoneal Cancer Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor Stage IV Fallopian Tube Cancer Stage IV Ovarian Cancer Stage IV Primary Peritoneal Cancer Stage IV Uterine Corpus Cancer Stage IVA Cervical Cancer Stage IVA Vaginal Cancer Stage IVB Cervical Cancer Stage IVB Vaginal Cancer Stage IVB Vulvar Cancer Uterine Corpus Cancer Uterine Corpus Leiomyosarcoma Vulvar Squamous Cell Carcinoma
Interventions
OTHER
No Results Yet
NCT00833625 | COMPLETED | NA
31 Participants

FDG-PET-CT and Biomarkers in Esophageal Cancer

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2009-02-28
Completion: 2015-12-31
Conditions
Gastrointestinal Disease Esophageal Cancer
Interventions
PROCEDURE OTHER
No Results Yet
NCT00806936 | COMPLETED
4847 Participants

Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes Subjects

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 2008-12-31
Completion: 2009-12-31
Conditions
Diabetes Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00771680 | COMPLETED
10408 Participants

Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 2008-10-31
Completion: 2010-07-31
Conditions
Diabetes Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00761475 | COMPLETED | PHASE3
480 Participants

Primary Mesh Closure of Abdominal Midline Wounds

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2009-02-28
Completion: 2012-12-31
Conditions
Incisional Hernia Occurence
Interventions
PROCEDURE
No Results Yet
NCT00709475 | COMPLETED
747 Participants

Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 2008-05-31
Completion: 2009-10-31
Conditions
Diabetes Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00706017 | COMPLETED
2282 Participants

Observational Study to Evaluate the Safety of Levemir® in Diabetes

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 2007-09-30
Completion: 2008-07-31
Conditions
Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00700765 | COMPLETED
1531 Participants

Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 2008-01-31
Completion: 2008-07-31
Conditions
Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00698269 | COMPLETED
5926 Participants

An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 2008-02-29
Completion: 2009-08-31
Conditions
Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00698126 | COMPLETED
4099 Participants

Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 2007-10-31
Completion: 2009-05-31
Conditions
Diabetes Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00687284 | COMPLETED
2188 Participants

Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 2008-02-29
Completion: 2010-06-30
Conditions
Diabetes Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00675220 | COMPLETED
373 Participants

Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 2007-06-30
Completion: 2007-12-31
Conditions
Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Delivery Systems
Interventions
DRUG
No Results Yet
NCT00670722 | COMPLETED
6500 Participants

Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 2008-01-31
Completion: 2009-12-31
Conditions
Diabetes Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00665808 | COMPLETED
8125 Participants

Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 2007-10-31
Completion: 2008-12-31
Conditions
Diabetes Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00655044 | COMPLETED
3637 Participants

Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 2007-05-31
Completion: 2008-01-31
Conditions
Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00638235 | COMPLETED
725 Participants

Pelvic Floor Repair Systems for Prolapse Repair

Study Type: OBSERVATIONAL
Last Updated: 2016-10-28
Start Date: 2006-05-31
Completion: 2011-02-28
Conditions
Pelvic Organ Prolapse
Interventions
DEVICE
Results Available
NCT00606385 | UNKNOWN | NA
84 Participants

Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCC

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2007-12-31
Completion: 2017-06-30
Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE
No Results Yet
NCT00545779 | COMPLETED | PHASE3
677 Participants

BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2006-12-31
Completion: 2008-10-31
Conditions
Post-Menopausal Osteoporosis
Interventions
DRUG
Results Available
NCT00523913 | COMPLETED | PHASE3
70 Participants

A Study Of BRL49653C For The Treatment Of Type 2 Diabetes

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2005-11-30
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG
No Results Yet
NCT00478504 | COMPLETED | PHASE4
159 Participants

Letrozole Versus Clomifene Citrate for Ovulation Induction

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2007-05-31
Completion: 2014-06-30
Conditions
Infertility Polycystic Ovarian Syndrome
Interventions
DRUG
No Results Yet
NCT00460148 | COMPLETED | PHASE2
28 Participants

Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2007-04-30
Conditions
Parkinson Disease
Interventions
DRUG
No Results Yet
NCT00452686 | COMPLETED | PHASE3
660 Participants

Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2007-03-31
Conditions
Diphtheria Acellular Pertussis Tetanus
Interventions
BIOLOGICAL
No Results Yet
NCT00422604 | COMPLETED | PHASE2
60 Participants

Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2006-10-31
Completion: 2007-05-31
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG
No Results Yet
NCT00413023 | COMPLETED | PHASE2
348 Participants

Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2005-06-30
Completion: 2006-09-30
Conditions
Depressive Disorder, Major
Interventions
DRUG
No Results Yet
NCT00411697 | COMPLETED | PHASE4
301 Participants

Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2006-12-31
Completion: 2007-05-31
Conditions
Hepatitis B
Interventions
BIOLOGICAL
No Results Yet
NCT00411073 | COMPLETED | PHASE1
72 Participants

Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2006-12-31
Conditions
Atherosclerosis
Interventions
DRUG
No Results Yet
NCT00400608 | COMPLETED | PHASE4
28 Participants

A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2006-10-31
Conditions
Asthma
Interventions
DRUG
No Results Yet
NCT00394056 | COMPLETED | PHASE2
26 Participants

Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2006-12-31
Completion: 2009-08-31
Conditions
Tinnitus
Interventions
DRUG OTHER
No Results Yet
NCT00381667 | COMPLETED | PHASE2
14 Participants

Study to Assess GW642444 in Asthma Patients

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2006-08-31
Completion: 2007-01-31
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG OTHER
No Results Yet
NCT00373542 | COMPLETED | PHASE4
39 Participants

12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2006-10-31
Completion: 2007-06-30
Conditions
Restless Legs Syndrome (RLS) Restless Legs Syndrome
Interventions
DRUG
No Results Yet
NCT00370227 | COMPLETED | PHASE3
390 Participants

Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2006-10-31
Conditions
Infections, Streptococcal
Interventions
BIOLOGICAL
No Results Yet
NCT00358488 | COMPLETED | PHASE2
54 Participants

Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2006-04-30
Completion: 2007-01-31
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG
No Results Yet
NCT00355641 | COMPLETED | PHASE3
450 Participants

Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2005-10-31
Completion: 2007-10-31
Conditions
Restless Legs Syndrome
Interventions
DRUG
No Results Yet
NCT00346749 | TERMINATED | PHASE4
180 Participants

ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2006-12-31
Completion: 2007-07-31
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG
No Results Yet
NCT00345956 | COMPLETED | PHASE3
375 Participants

To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2006-09-30
Conditions
Infections, Rotavirus
Interventions
BIOLOGICAL
No Results Yet
NCT00296530 | COMPLETED | PHASE4
600 Participants

Study Of Patients With Allergic Rhinitis And Asthma

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2005-09-30
Completion: 2007-07-31
Conditions
Asthma
Interventions
DRUG
No Results Yet
NCT00264667 | COMPLETED | PHASE2
290 Participants

Study In Patients With Dyslipidaemia

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2005-12-31
Conditions
Metabolic Syndrome X
Interventions
DRUG
No Results Yet
NCT00224523 | COMPLETED | PHASE3
125 Participants

Long Term Safety Of GW685698X Via Nasal Biopsy

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2005-09-30
Completion: 2007-02-28
Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG
No Results Yet
NCT00144911 | COMPLETED | PHASE4
740 Participants

ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.

Study Type: INTERVENTIONAL
Last Updated: 2016-10-28
Start Date: 2004-10-31
Completion: 2006-12-31
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page